Scanning Beam Proton Therapy versus Photon IMRT for Stage III Lung Cancer: Comparison of Dosimetry, Toxicity, and Outcomes

Purpose: There are limited clinical data on scanning-beam proton therapy (SPT) in treating locally advanced lung cancer, as most published studies have used passive-scatter technology. There is increasing interest in whether the dosimetric advantages of SPT compared with photon therapy can translate...

Full description

Bibliographic Details
Main Authors: Zhenwei Zou, MD, Stephen R. Bowen, PhD, Hannah M.T. Thomas, MD, Balu Krishna Sasidharan, MD, Ramesh Rengan, MD, PhD, Jing Zeng, MD
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Advances in Radiation Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S245210942030052X